Notably, in some MPN patients, JAK2 is expressed in fusion with a centrosomal protein PCM1 [48–50] and can reside at the centrosome with readily detectable kinase activity, which is likely to result from the dimerization of the centrosomal protein. This evidence concerns the gene JAK2 and myeloproliferative disorder.